News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,524 Results
Type
Article (5186)
Company Profile (41)
Press Release (194296)
Multimedia
Podcasts (11)
Webinars (7)
Section
Business (62784)
Career Advice (304)
Deals (10881)
Drug Delivery (32)
Drug Development (9374)
Employer Resources (28)
FDA (5257)
Job Trends (4572)
News (81129)
Policy (6076)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (3)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (650)
Accelerated approval (5)
ADA (9)
Allergies (54)
Alliances (18976)
ALS (46)
Alzheimer's disease (407)
Antibody-drug conjugate (ADC) (80)
Approvals (5650)
Artificial intelligence (497)
ASCO (25)
Autoimmune disease (74)
Automation (60)
Bankruptcy (70)
Belgium (24)
Best Places to Work (4198)
BIO (20)
Biologics (28)
BIOSECURE Act (3)
Biosimilars (92)
BioSpace Insights (41)
Biotechnology (27)
Bispecific (6)
Bladder cancer (59)
Brain cancer (15)
Breast cancer (162)
Cancer (1406)
Cardiovascular disease (120)
Career advice (276)
Career pathing (14)
CAR-T (62)
CDC (4)
CDMO (47)
Cell therapy (214)
Cervical cancer (26)
Clinical research (8815)
Collaboration (1169)
Commercialization (21)
Compensation (157)
Complete response letters (14)
COVID-19 (534)
CRISPR (44)
CRO (1)
C-suite (456)
Cystic fibrosis (30)
Data (1968)
Decentralized trials (2)
Denatured (9)
Depression (36)
Dermatology (67)
Diabetes (181)
Diagnostics (3639)
Digital health (47)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (156)
Drug pricing (30)
Drug shortages (4)
Duchenne muscular dystrophy (21)
Earnings (18975)
Editorial (9)
Employer resources (28)
ESMO (47)
Events (25980)
Executive appointments (464)
Eye disease (2)
FDA (6916)
Fragile X (1)
Funding (719)
Gene editing (65)
Generative AI (30)
Gene therapy (160)
GLP-1 (209)
Government (788)
Grass and pollen (2)
Guidances (175)
Healthcare (6266)
Hematology (28)
HIV (55)
Huntington's disease (5)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (14)
Immunology and inflammation (17)
Immuno-oncology (16)
Indications (84)
Infectious disease (638)
Inflammatory bowel disease (57)
Inflation Reduction Act (2)
Influenza (42)
Intellectual property (99)
Interviews (43)
IPO (4425)
IRA (5)
Job creations (529)
Job search strategy (215)
JPM (6)
Kidney cancer (3)
Kidney disease (14)
Labor market (19)
Layoffs (53)
Leadership (13)
Legal (1074)
Licensing (18)
Liver cancer (13)
Longevity (18)
Lung cancer (193)
Lung diease (4)
Lymphoma (98)
Machine learning (35)
Management (13)
Manufacturing (643)
Marketing (10)
MASH (21)
Medical affairs (2)
Medical device (7559)
Medtech (7767)
Mergers & acquisitions (7185)
Metabolic disorders (339)
mRNA (37)
Multiple sclerosis (42)
Multispecific (2)
NASH (1)
Netherlands (13)
Neurodegenerative disease (110)
Neuropsychiatric disorders (12)
Neuroscience (776)
Neurotech (1)
NextGen: Class of 2026 (2444)
Non-profit (1078)
Now hiring (8)
Obesity (119)
Opinion (70)
Ovarian cancer (35)
Pain (138)
Pancreatic cancer (74)
Parkinson's disease (93)
Partnered (22)
Patents (225)
Patient advocacy (3)
Patient recruitment (187)
Patient selection (13)
Peanut (19)
People (15391)
Peptides (15)
Pharmaceutical (9)
Pharmacy benefit managers (15)
Phase 1 (2112)
Phase 2 (3395)
Phase 3 (3763)
Pipeline (3762)
Policy (39)
Postmarket research (361)
Preclinical (989)
Press Release (19)
Prostate cancer (90)
Psychedelics (5)
Radioligand (1)
Radiopharmaceuticals (125)
Rare diseases (257)
Real estate (1781)
Recruiting (8)
Regenerative medicine (13)
Regulatory (6067)
Reports (22)
Research institute (673)
Resumes & cover letters (47)
Rett syndrome (11)
RNA editing (3)
RSV (21)
Schizophrenia (17)
Series A (136)
Series B (76)
Service/supplier (5)
Sickle cell disease (13)
Special edition (1)
Spinal muscular atrophy (43)
Sponsored (27)
Startups (858)
State (1)
Stem cells (1)
Stomach cancer (1)
Substance use disorders (6)
Supply chain (68)
Switzerland (1)
Tariffs (9)
The Weekly (2)
Vaccines (229)
Venture capital (17)
Weight loss (78)
Women's health (98)
Worklife (4)
Date
Today (39)
Last 7 days (189)
Last 30 days (778)
Last 365 days (8524)
2026 (7270)
2025 (8643)
2024 (10545)
2023 (11690)
2022 (17544)
2021 (18696)
2020 (18865)
2019 (16743)
2018 (12085)
2017 (9466)
2016 (8820)
2015 (9684)
2014 (7053)
2013 (6035)
2012 (6401)
2011 (6263)
2010 (4943)
Location
Africa (158)
Alabama (27)
Alaska (2)
Arizona (137)
Arkansas (6)
Asia (10364)
Australia (1388)
California (4152)
Canada (1333)
China (415)
Colorado (283)
Connecticut (170)
Delaware (150)
Europe (27445)
Florida (792)
Georgia (255)
Hawaii (2)
Idaho (44)
Illinois (688)
India (71)
Indiana (455)
Iowa (13)
Japan (201)
Kansas (44)
Kentucky (28)
Louisiana (28)
Maine (40)
Maryland (449)
Massachusetts (2303)
Michigan (222)
Minnesota (453)
Mississippi (5)
Missouri (102)
Montana (19)
Nebraska (12)
Nevada (54)
New Hampshire (52)
New Jersey (1403)
New Mexico (21)
New York (829)
North Carolina (831)
North Dakota (10)
Northern California (1908)
Ohio (233)
Oklahoma (14)
Oregon (20)
Pennsylvania (840)
Puerto Rico (4)
Rhode Island (29)
South America (301)
South Carolina (76)
South Dakota (1)
Southern California (1771)
Tennessee (99)
Texas (732)
United States (16129)
Utah (156)
Vermont (2)
Virginia (109)
Washington D.C. (19)
Washington State (247)
West Virginia (2)
Wisconsin (122)
Wyoming (1)
199,524 Results for "ion solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
October 15, 2026
·
6 min read
Press Releases
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
August 17, 2026
·
2 min read
Press Releases
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
November 3, 2026
·
7 min read
Press Releases
Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830
October 19, 2026
·
7 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
·
5 min read
Press Releases
Hiteck Congratulates the 2026 Nobel Laureates in Physiology or Medicine, Including Professor Georg Nagel, Scientific Advisor to Investee Company Augelux Therapeutics
The Nobel Prize honors the discovery of light-gated ion channels. At Augelux, that discovery is now being tested as a way to restore sight.
October 8, 2026
·
1 min read
Press Releases
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora’s ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa
June 18, 2026
·
4 min read
Press Releases
IBA signs major contract for a high-throughput Be Efficient sterilization solution in Germany
October 23, 2026
·
3 min read
Press Releases
AbTherx Expands Platform and Leadership Team to Unlock Antibody Discovery for Multispecifics, Enzymes, GPCRs, and Ion Channels
June 10, 2026
·
4 min read
Deals
Biohaven could get up to $795M in epilepsy alliance with SK Bio
At the center of Biohaven’s agreement with SK Biopharmaceutical is the ion channel platform and the lead epilepsy candidate opakalim, for which Phase 2/3 data are expected later this year.
August 26, 2026
·
2 min read
·
Tristan Manalac
1 of 19,953
Next
